BUDIO THOMAS: Open Payments
NPI 1306948286 · EAST PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 44 payments from 11 companies in 2025. Trend: 2023 $1,548 · 2024 $1,287 · 2025 $1,106
Food & beverage: $1,106
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $295 |
| ABBVIE INC. | 7 | $252 |
| Novo Nordisk Inc | 8 | $167 |
| Amgen Inc. | 5 | $124 |
| Abbott Laboratories | 4 | $95 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
Products named: QULIPTA, AIRSUPRA, FARXIGA, FREESTYLE LIBRE 3, CREON, OTEZLA, Ozempic, JARDIANCE.
Industry payments across RI — which companies pay providers there.
